Rv3245c - c.-92G>C
Drug resistance types
2 Sensitive
2 RR-TB
8 HR-TB
4 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
15 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.9 | 16 |
| lineage4.9;lineage7 | 2 |
| La1.7.X-unk4;lineage4.9 | 1 |
| La3;lineage4.9 | 6 |
| La3;lineage4.3.4 | 1 |
| lineage2.1;lineage4.9 | 1 |
| La1.7;lineage4.9 | 2 |
| lineage2.2.1 | 1 |
| lineage2.1;lineage4.9;lineage7 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 31 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | ERR4816466 | HR-TB | lineage4.9 | None | SRR3675539 | MDR-TB | lineage4.9;lineage7 | None | SRR3675520 | Other | La1.7.X-unk4;lineage4.9 | None | ERR4188247 | HR-TB | lineage4.9 | None | ERR3797048 | Other | La3;lineage4.9 | None | SRR3675231 | MDR-TB | lineage4.9;lineage7 | None | ERR3283031 | Other | La3;lineage4.9 | None | ERR926154 | Sensitive | lineage4.9 | None | ERR926157 | Other | lineage4.9 | None | ERR161039 | HR-TB | La3;lineage4.3.4 | None | ERR3797064 | Other | La3;lineage4.9 | None | ERR1035138 | MDR-TB | lineage2.1;lineage4.9 | None | ERR161037 | HR-TB | lineage4.9 | None | ERR3797029 | Other | lineage4.9 | None | ERR212034 | HR-TB | La1.7;lineage4.9 | None | ERR926165 | Other | lineage4.9 | None | ERR387051 | RR-TB | lineage4.9 | None | ERR736848 | Other | lineage4.9 | None | ERR926160 | Other | lineage4.9 | None | ERR3283011 | Other | La3;lineage4.9 | None | SRR6046382 | RR-TB | lineage2.2.1 | None | ERR3283047 | Sensitive | La3;lineage4.9 | None | ERR926163 | Other | lineage4.9 | None | ERR181744 | HR-TB | La3;lineage4.9 | None | SRR8217918 | HR-TB | lineage4.9 | None | ERR926164 | Other | lineage4.9 | None | SRR10808730 | Other | lineage4.9 | None | ERR926155 | Other | lineage4.9 | None | ERR971389 | Other | lineage4.9 | None | ERR176560 | HR-TB | La1.7;lineage4.9 | None | SRR3675555 | MDR-TB | lineage2.1;lineage4.9;lineage7 | None |
|---|
